Objectives Camelid nanobodies (single-domain antibodies) are emerging as a promising tool in nuclear medicine for both molecular imaging and theranostics. Nanobodies have a low molecular mass (12-15 kDa), allowing for deep tumor penetration and rapi...
Markdown supported · ⌘↵ to post
No responses yet.